Related Experiment Videos
Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma
Michelle D Jones1, Ellen J Hess
1Department of Neurology, Johns Hopkins University School of Medicine, Meyer 6-181, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Pharmacology, Biochemistry, and Behavior
|May 22, 2003
Summary
The coloboma mouse model shows hyperactivity due to reduced SNAP-25, leading to altered dopamine and norepinephrine levels. Reducing norepinephrine significantly decreased hyperactivity, highlighting its role in attention deficit hyperactivity disorder (ADHD).
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Dopaminergic and noradrenergic system imbalances are linked to hyperactivity disorders like ADHD and Tourette syndrome.
- The coloboma mouse mutant displays spontaneous locomotor hyperactivity, offering a model for neurological hyperactivity research.
Purpose of the Study:
- To investigate the neurological underpinnings of hyperactivity in the coloboma mouse model.
- To determine the specific role of norepinephrine (NE) in the expression of hyperactivity.
Main Methods:
- Characterized the coloboma mouse model, noting reduced SNAP-25 and altered catecholamine levels (decreased dopamine utilization, increased norepinephrine).
- Administered the neurotoxin DSP-4 to specifically deplete brain norepinephrine concentrations in coloboma mice.
- Assessed the impact of NE depletion on locomotor activity in coloboma mice via systemic and central administration.
Main Results:
- Coloboma mice exhibit reduced SNAP-25, leading to hyperactivity and altered dopamine/norepinephrine balance.
- DSP-4 treatment effectively reduced NE levels without affecting dopamine or serotonin.
- Depletion of NE significantly reduced locomotor activity in hyperactive coloboma mice.
Conclusions:
- Central nervous system norepinephrine regulation is crucial for hyperactivity expression in the coloboma mouse model.
- Findings support the role of NE in ADHD pathophysiology and align with existing models of the disorder.